Materials & Resources » Chemicals | ChromaDex Corp.

ChromaDex Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,261.30
3,964.80
5,549.70
1,642.40
45,388.80
22,616
Total Accounts Receivable
1,053.80
1,906.70
2,450.60
5,852.00
5,337.90
5,092
Inventories
2,204.10
3,734.30
8,173.80
7,912.60
5,796.30
8,249
Other Current Assets
271.40
292.90
373.60
329.90
655.30
577
Total Current Assets
5,790.70
9,898.70
16,547.60
15,736.90
57,178.30
36,534
Net Property, Plant & Equipment
1,063.20
1,264.70
1,788.60
1,778.20
2,871.90
3,585
Total Investments and Advances
1,887.80
-
-
20.30
750.40
323
Intangible Assets
201.70
296.10
354.10
486.20
1,651.40
1,547
Other Assets
43.50
148.80
58.90
1,730.40
271.60
243
Total Assets
8,986.90
11,608.20
18,749.20
19,752.10
62,723.60
42,232
ST Debt & Current Portion LT Debt
138.90
371.60
1,748.30
255.50
195.50
Accounts Payable
1,440.90
3,451.60
6,224.00
5,978.30
3,718.40
Other Current Liabilities
1,258.30
1,157.60
1,614.40
2,635.40
4,174.00
Total Current Liabilities
2,838.10
4,980.80
9,586.60
8,869.20
8,087.90
Long-Term Debt
280.30
2,491.50
3,789.90
343.60
310.10
Other Liabilities
203.00
137.50
98.00
565.00
491.90
Total Liabilities
3,321.40
7,609.80
13,474.50
9,777.70
8,889.90
Common Equity (Total)
5,665.50
3,998.40
5,274.70
9,974.40
53,833.70
Total Shareholders' Equity
5,665.50
3,998.40
5,274.70
9,974.40
53,833.70
Total Equity
5,665.50
3,998.40
5,274.70
9,974.40
53,833.70
Liabilities & Shareholders' Equity
8,986.90
11,608.20
18,749.20
19,752.10
62,723.60

About ChromaDex

View Profile
Address
10900 Wilshire Boulevard
Los Angeles California 90024
United States
Employees -
Website http://www.chromadex.com
Updated 07/08/2019
Chromadex Corp. engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It operates through the following segments: Ingredients, Consumer Products, and Core Standards & Contract Services. The Ingredients segment offers developing and commercializing proprietary-based ingredient technologies.